15 unknown. 15 Phase 2, 5 Phase 1, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 15 | Unknown 15 |
| Phase 1 | 5 | Unknown 5 |
| Phase 3 | 2 | Unknown 2 |
Follow Influenza, Human: new trials by email Literature Review of Influenza, Human trials Research Report on Influenza, Human
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety, Tolerability, Immunogenicity and Immunological Mechanisms of TETRALITE, a Novel Seasonal Influenza Vaccine TETRALITE - Vaccination Reaction | Phase 1 / Phase 2 | Unknown | LiteVax BV | 84 | 2024-01-29 | 2024-07-29 |
| Dose, Safety, and Pathogenicity of a New Influenza B Strain influenza B/Connecticut/1/21 virus part a dose arm 1, influenza B/Connecticut/1/21 virus part a dose arm 2, influenza B/Connecticut/1/21 virus part b dose 1 - Influenza B | Phase 2 | Unknown | Hvivo | 60 | 2023-10-03 | 2024-02-12 |
| A Randomized, Double-blind, Placebo-controlled, Multicenter and Phase Ⅱa Clinical Trial for the Effectiveness and Safety of Baicalein Tablets in the Treatment of Improve Other Aspects of Healthy Adult With Influenza Fever Baicalein Tablets 400mg, Baicalein Tablets 600mg, blank control 0mg - Influenza | Phase 2 | Unknown | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 180 | 2019-02-01 | 2019-02-05 |
| Flufenamic Acid for Hospitalised Influenza Infection FFA, clarithromycin, oseltamivir, Oseltamivir alone - Influenza A | Phase 2 | Unknown | The University of Hong Kong | 200 | 2018-01-08 | 2019-10-22 |
| Study of the Immunogenicity and Safety of a Quadrivalent Influenza Vaccine (VAX2012Q) in Adults 18-64 Years VAX2012Q, Fluzone Quadrivalent - Influenza | Phase 2 | Unknown | VaxInnate Corporation | 450 | 2015-05-01 | 2015-06-26 |
| A Clinical Study of Treating Influenza With Liugan Shuangjie Heji Liugan Shuangjie Heji, Shufeng Jiedu Capsule, Oseltamivir Phosphate Capsule - Influenza | Phase 1 / Phase 2 | Unknown | Dongfang Hospital Beijing University of Chinese Medicine | 300 | 2014-11-01 | 2015-10-09 |
| Study of Safety and Immunogenicity of a Quadrivalent Influenza Vaccine in Healthy Adults Age 65-75 Years VAX2012Q, Placebo - Influenza | Phase 1 / Phase 2 | Unknown | VaxInnate Corporation | 200 | 2014-11-01 | 2015-04-17 |
| Influenza Virus Challenge Study to Test Monoclonal Antibody TCN-032 as a Treatment for Influenza TCN-032, Placebo (saline) - Influenza | Phase 2 | Unknown | Theraclone Sciences, Inc. | 64 | 2012-08-01 | 2012-11-01 |
| Assessment of Needle-free Disposable-syringe Jet Injector (DSJI) ID Dose-sparing of Pandemic A H1N1 Influenza Vaccine 2012 trivalent influenza vaccine - Influenza | Phase 2 / Phase 3 | Unknown | University of Sao Paulo General Hospital | 300 | 2012-07-01 | 2012-06-21 |
| Evaluate the Immunogenicity and Safety of the 2011-2012 Vaccine Against Seasonal Influenza on Pregnant Women Seasonal influenza vaccination - Pregnancy, Investigation or Care in A Nonpregnant Woman | Phase 2 / Phase 3 | Unknown | Instituto Nacional de Salud Publica, Mexico | 240 | 2012-04-01 | 2012-04-13 |
| Safety and Efficacy Study of Interferon to Treat Patients Hospitalized for Influenza Interferon alfacon-1, Placebo - Influenza | Phase 1 / Phase 2 | Unknown | University Health Network, Toronto | 30 | 2010-11-01 | 2010-10-25 |
| Vaccination Against Influenza H1N1 in Rheumatic Diseases Focetria (Monovalent MF59-Adjuvanted vaccine) - Influenza, Rheumatic Diseases | Phase 2 | Unknown | Tel-Aviv Sourasky Medical Center | 400 | 2009-11-01 | 2009-11-03 |
| The Chloroquine for Influenza Prevention Trial Chloroquine, Placebo - Influenza | Phase 2 | Unknown | National University Hospital, Singapore | 1516 | 2009-11-01 | 2010-03-02 |
| Basic and Clinical Research on Applying Blood Fix to Treat Critical H1N1 Patients split-virion, non-adjuvanted H1N1 vaccine of 15 μg, blood fix - Virus Diseases, Respiratory Tract Diseases | Phase 2 | Unknown | Shanghai Public Health Clinical Center | 7 | 2009-10-01 | 2010-01-26 |
| Evaluation of the Safety and Effectiveness of a Probiotic Bacterium to Boost the Immune Response to Influenza Vaccines Fluvax, PCC® (Lactobacillus fermentum VRI 003) - Influenza | Phase 1 / Phase 2 | Unknown | Probiomics Ltd | 300 | 2006-03-01 | 2007-01-09 |
Orthomyxoviridae Infections (2) · Arthritis, Psoriatic (1) · Respiratory Tract Diseases (1) · Respiratory Tract Infections (1) · Rheumatic Diseases (1) · Virus Diseases (1)
Infections (15) · RNA Virus Infections (15) · Respiratory Tract Diseases (14) · Respiratory Tract Infections (14) · Virus Diseases (14) · Orthomyxoviridae Infections (13) · Arthritis (1) · Bone Diseases (1) · Connective Tissue Diseases (1) · Joint Diseases (1) · Musculoskeletal Diseases (1) · Psoriasis (1) · Skin Diseases (1) · Skin Diseases, Papulosquamous (1) · Skin and Connective Tissue Diseases (1)
Oseltamivir (2) · Antiviral Agents (1) · Chloroquine (1) · Clarithromycin (1) · Fatty Acids, Nonesterified (1) · Hydroxychloroquine (1) · Sodium Chloride (1) · baicalein (1) · chloroquine diphosphate (1) · focetria (1) · interferon alfacon-1 (1) · shufeng jiedu (1)
VaxInnate Corporation (2) · CSPC ZhongQi Pharmaceutical Technology Co., Ltd. (1) · Dongfang Hospital Beijing University of Chinese Medicine (1) · Hvivo (1) · Instituto Nacional de Salud Publica, Mexico (1) · LiteVax BV (1) · National University Hospital, Singapore (1) · Probiomics Ltd (1) · Shanghai Public Health Clinical Center (1) · Tel-Aviv Sourasky Medical Center (1) · The University of Hong Kong (1) · Theraclone Sciences, Inc. (1) · University Health Network, Toronto (1) · University of Sao Paulo General Hospital (1)
Australia (2) · China (2) · United Kingdom (2) · Belgium (1) · Brazil (1) · Canada (1) · Hong Kong (1) · Mexico (1) · Singapore (1) · United States (1)
Dante Morra, MD, MBA (1) · Eleanor L Ramos, MD (1) · Glacus Brito, MD (1) · Hong-zhou Lu, Professor (1) · Ivan Hung, MD FRCP (1) · Lawrence Lee, MD PhD (1) · Lourdes Garcia Garcia, DCs (1) · Lynda Tussey, PHD (1) · Nicholas I Paton, MD FRCP (1) · Qingquan Liu, Professor (1) · Ronald Penny, DSc, MD, FRACP (1) · Stephen J. Haworth, MD (1) · Victoria Parker, MBBS (1)
PMID 21425247, PMID 21550310, PMID 21767595, PMID 25281755, PMID 41313942
2023 (1)